Two Sigma Advisers’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $398K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $446K | Sell |
|
|||||
|
2024
Q2 | $4.79M | Sell |
|
|||||
|
2024
Q1 | $26.9M | Sell |
|
|||||
|
2023
Q4 | $27.7M | Sell |
|
|||||
|
2023
Q3 | $33.2M | Sell |
|
|||||
|
2023
Q2 | $52.3M | Sell |
|
|||||
|
2023
Q1 | $68.7M | Sell |
|
|||||
|
2022
Q4 | $86.3M | Buy |
|
|||||
|
2022
Q3 | $63.2M | Buy |
|
|||||
|
2022
Q2 | $45.3M | Sell |
|
|||||
|
2022
Q1 | $58.9M | Buy |
|
|||||
|
2021
Q4 | $16.5M | Buy |
|
|||||
|
2021
Q3 | $1.62M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $41.4M | Sell |
|
|||||
|
2020
Q2 | $88.8M | Buy |
|
|||||
|
2020
Q1 | $62.2M | Sell |
|
|||||
|
2019
Q4 | $89.3M | Buy |
|
|||||
|
2019
Q3 | $66M | Sell |
|
|||||
|
2019
Q2 | $67.5M | Buy |
|
|||||
|
2019
Q1 | $66.7M | Buy |
|
|||||
|
2018
Q4 | $44.5M | Buy |
|
|||||
|
2018
Q3 | $67.1M | Buy |
|
|||||
|
2018
Q2 | $30.2M | Buy |
|
|||||
|
2018
Q1 | $2.46M | Buy |
|
|||||
|
2017
Q4 | $862K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $534K | Sell |
|
|||||
|
2017
Q1 | $801K | Hold |
|
|||||
|
2016
Q4 | $716K | Buy |
|
|||||
|
2016
Q3 | $363K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $1.58M | Buy |
|
|||||
|
2015
Q4 | $1.67M | Sell |
|
|||||
|
2015
Q3 | $2.68M | Buy |
|
|||||
|
2015
Q2 | $887K | Buy |
|
|||||
|
2015
Q1 | $634K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $275K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $170K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $189K | Buy |
|